butabarbital decreases outcomes of hemin by pharmacodynamic antagonism. Use Warning/Monitor. Medicine that raise delta-aminolevulinic acid synthetase could reduce hemin outcome.butabarbital will lessen the extent or outcome of carvedilol by influencing hepatic enzyme CYP2C9/10 metabolism. Use Warning/Keep track of.Making use of this drugs with any